Olek Elizabeth A

SR VP, CLINICAL SCIENCE at Kronos Bio, Inc.; SVP and CMO at ACHILLION PHARMACEUTICALS INC

Sold, on record
$133k
Dollars the filings state
Form 4 sales
2
Latest Feb 21, 2024
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Jan 10, 2012 2012

    Sold 12,468 shares at $10.06 ($125k)

    Olek Elizabeth A, SVP and CMO

    Sold 86.2% of holdings ($146k position)2,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Kronos Bio, Inc.No plan
    Feb 21, 2024 +4425 days

    Sold 7,368 shares at $1.05 ($8k)

    Olek Elizabeth A, SR VP, CLINICAL SCIENCE

    No 10b5-1 planSold 3.7% of holdings ($211k position)193,275 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Olek Elizabeth A
Source
Feb 21, 2024Feb 23, 2024Kronos Bio, Inc.SR VP, CLINICAL SCIENCEForm 4 sale7,368$8k3.7%No planSEC
Jan 10, 2012Jan 11, 2012ACHILLION PHARMACEUTICALS INCSVP and CMOForm 4 sale12,468$125k86.2%UnusualSEC